The DOI matches its Crossref record; 143 of the 145 references it cites were found in a registry or an index.
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Open accessAbstract
OBJECTIVE: Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. PARTICIPANTS: The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, six additional experts, one methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. EVIDENCE: Systematic reviews of available evidence were used to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group criteria to describe both the quality of evidence and the strength of recommendations. We used "recommend" for strong recommendations and "suggest" for weak recommendations. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions during one group meeting, several conference calls, and multiple e-mail communications. The drafts prepared by the task force with the help of a medical writer were reviewed successively by The Endocrine Society's CGS, Clinical Affairs Core Committee (CACC), and Council. The version approved by the CGS and CACC was placed on The Endocrine Society's Web site for comments by members. At each stage of review, the Task Force received written comments and incorporated needed changes. CONCLUSIONS: We recommend case detection of primary aldosteronism be sought in higher risk groups of hypertensive patients and those with hypokalemia by determining the aldosterone-renin ratio under standard conditions and that the condition be confirmed/excluded by one of four commonly used confirmatory tests. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend the presence of a unilateral form of primary aldosteronism should be established/excluded by bilateral adrenal venous sampling by an experienced radiologist and, where present, optimally treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, optimally be treated medically by mineralocorticoid receptor antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mineralocorticoid excess can be caused by either bilateral hyperplasia or ACA, and these lesions are usually small (<2 cm) (115).”
From Adrenocortical carcinoma (2014) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Self-citationLifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
Self-citationMulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Self-citationA Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Self-citationIncidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Flagged first, then by citations
2 of the 145 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Ganguly, 1976, Spironolactone therapy in primary aldosteronism: diagnostic and therapeutic implications, In: Sambhi MP, ed. Systemic effects of antihypertensive agents. New York: Stratton;, 383
Cited by
Sorted by citations
Items 301–400 of 1,000
ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions
Mulatero, P., Schiavi, F., Williams, T. A., Monticone, S., Barbon, G., Opocher, G., & Fallo, F. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.98 · Cited by 50
Primary aldosteronism as a cause of secondary osteoporosis
Salcuni, A. S., Carnevale, V., Battista, C., Palmieri, S., Eller-Vainicher, C., Guarnieri, V., Pugliese, F., Guglielmi, G., Desina, G., Minisola, S., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0417 · Cited by 49
Eligibility for percutaneous renal denervation
Verloop, W. L., Vink, E. E., Voskuil, M., Vonken, E.-J. P. A., Rookmaaker, M. B., Bots, M. L., Doevendans, P. A., Blankestijn, P. J., & Spiering, W. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328362152e · Cited by 49
Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis
Sconfienza, E., Tetti, M., Forestiero, V., Veglio, F., Mulatero, P., & Monticone, S. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad044 · Cited by 50
Understanding primary aldosteronism: impact of next generation sequencing and expression profiling
Monticone, S., Else, T., Mulatero, P., Williams, T. A., & Rainey, W. E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.015 · Cited by 49
Rossi, E., Regolisti, G., Perazzoli, F., Negro, A., Grasselli, C., Santi, R., Cavalieri, S., Belloni, L., Gemelli, G., Valle, E. D. O., et al. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.148 · Cited by 49
Rossi, G. P., Cesari, M., Letizia, C., Seccia, T. M., Cicala, M. V., Zinnamosca, L., Kuppusamy, M., Mareso, S., Sciomer, S., Iacobone, M., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000186 · Cited by 49
Self-citationAdrenal surgery in England: better outcomes in high‐volume practices
Palazzo, F. F., Dickinson, A., Phillips, B., Sahdev, A., Bliss, R., Rasheed, A. M., Krukowski, Z. H., & Newell-Price, J. D. C. (2016) · Clinical Endocrinology · doi:10.1111/cen.13021 · Cited by 49
Ahmed, A. H., Gordon, R. D., Taylor, P. J., Ward, G., Pimenta, E., & Stowasser, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0225 · Cited by 49
Self-citationAldosterone and cardiovascular disease
Carey, R. M. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283390fa4 · Cited by 48
Self-citationBomback, A. S., & Klemmer, P. J. (2009) · American Journal of Nephrology · doi:10.1159/000209744 · Cited by 48
Daimon, M., KAMBA, A., Murakami, H., Takahashi, K., Otaka, H., Makita, K., Yanagimachi, M., Terui, K., Kageyama, K., Nigawara, T., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3568 · Cited by 49
Liu, S. Y., Chu, C. C. M., Tsui, T. K. C., Wong, S. K. H., Kong, A. P. S., Chiu, P. W. Y., Chow, F. C. C., & Ng, E. K. (2016) · Radiology · doi:10.1148/radiol.2016152277 · Cited by 48
Aldosterone and Left Ventricular Remodeling
Colussi, G., Brosolo, G., Novello, M., Sechi, L. A., & Catena, C. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565055 · Cited by 48
Chen, Y., Lin, Y.-H., Huang, W., Chueh, E., Chen, L., Yang, S., Lin, P., Lin, L., Lin, Y., Wu, V., et al. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00019 · Cited by 48
Mulligan, G. B., Faiman, C., Gupta, M. K., Kennedy, L., Hatipoğlu, B., Hui, F. K., Weil, R. J., & Hamrahian, A. H. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04339.x · Cited by 52
Aldosterone: A cardiovascular risk factor?
Funder, J. W., & Reincke, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.08.005 · Cited by 47
Self-citationAdrenal Histopathology in Primary Aldosteronism
Gioco, F., Seccia, T. M., Gómez-Sánchez, E. P., Rossi, G. P., & Gómez-Sánchez, C. E. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05873 · Cited by 47
Sze, W.-C., Soh, L. M., Lau, J. H. G., Reznek, R. H., Sahdev, A., Matson, M. B., Riddoch, F., Carpenter, R., Berney, D. M., Grossman, A. B., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12374 · Cited by 47
Aldosterone to Renin Ratio – A Reliable Screening Tool for Primary Aldosteronism?
Tomaschitz, A., & Pilz, S. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1248326 · Cited by 46
Disorders of Potassium Balance
Mount, D. B., & Zandi‐Nejad, K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10017-x · Cited by 45
Update in adrenal venous sampling for primary aldosteronism
Rossi, G. P. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000407 · Cited by 47
Tang, L., Li, X., Wang, B., Ma, X., Li, H., Gao, Y., Gu, L., Nie, W., & Zhang, X. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4920841 · Cited by 47
A Diagnostic Approach to Adrenocortical Tumors
Hodgson, A., Pakbaz, S., & Mete, Ö. (2019) · Surgical pathology clinics · doi:10.1016/j.path.2019.08.005 · Cited by 48
Martínez‐Aguayo, A., Marlene Aglony, I., Campino, C., García, H., Bancalari, R. E., Bolte, L., Avalos, C., Loureiro, C., Carvajal, C. A., Ávila, A., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.155135 · Cited by 47
Self-citationRowe, N. E., Kumar, R., Schieda, N., Siddiqi, F. S., McGregor, T. B., McAlpine, K., Violette, P. D., Bathini, V., Eng, M. K., & Izard, J. (2023) · The Journal of Urology · doi:10.1097/ju.0000000000003644 · Cited by 54
Primary aldosteronism associated with subclinical Cushing syndrome.
Fujimoto, K., Honjo, S., Tatsuoka, H., Hamamoto, Y., Kawasaki, Y., Matsuoka, A., Ikeda, H., Wada, Y., Sasano, H., & Koshiyama, H. (2013) · PubMed · doi:10.3275/8818 · Cited by 46
Bomback, A. S., Rekhtman, Y., Klemmer, P. J., Canetta, P. A., Radhakrishnan, J., & Appel, G. B. (2012) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2012.07.003 · Cited by 46
Cornu, E., Steichen, O., Nogueira‐Silva, L., Küpers, E. M., Pagny, J.-Y., Grataloup, C., Baron, S., Zinzindohoué, F., Plouin, P., & Amar, L. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07214 · Cited by 46
Young, W. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00016-x · Cited by 46
Self-citationOta, H., Seiji, K., Kawabata, M., Satani, N., Omata, K., Ono, Y., Iwakura, Y., Morimoto, R., Matsuura, T., Kudo, M., et al. (2015) · European Radiology · doi:10.1007/s00330-015-3872-3 · Cited by 46
SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps
Douillard, C., Houillier, P., Nussberger, J., & Girerd, X. J. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.02.003 · Cited by 46
Differential diagnosis of primary aldosteronism subtypes
Mulatero, P., Bertello, C., Verhovez, A., Rossato, D., Giraudo, G., Mengozzi, G., Limerutti, G., Avenatti, E., Tizzani, D., & Veglio, F. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0038-1 · Cited by 45
Goupil, R., Wolley, M. J., Ahmed, A. H., Gordon, R. D., & Stowasser, M. (2015) · Clinical Endocrinology · doi:10.1111/cen.12750 · Cited by 45
Self-citationO’Toole, S. M., Sze, W.-C., Chung, T., Akker, S. A., Druce, M. R., Waterhouse, M., Pitkin, S. L., Dawnay, A., Sahdev, A., Matson, M. B., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa519 · Cited by 45
Hennings, J., Sundin, A., Hägg, A., & Hellman, P. (2010) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-010-0681-7 · Cited by 44
KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas [Rapid Communication]
Yamada, M., Nakajima, Y., Taguchi, R., Okamura, T., Ishii, S., Tomaru, T., Ozawa, A., Shibusawa, N., Yoshino, S., Toki, A., et al. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0247 · Cited by 44
The influence of aging on the diagnosis of primary aldosteronism
Nakama, C., Kamide, K., Kawai, T., Hongyo, K., Ito, N., Onishi, M., Takeya, Y., Yamamoto, K. I., Sugimoto, K., & Rakugi, H. (2014) · Hypertension Research · doi:10.1038/hr.2014.129 · Cited by 44
Reardon, M. A., Angle, J. F., Abi‐Jaoudeh, N., Bruns, D. E., Haverstick, D. M., Matsumoto, A. H., & Carey, R. M. (2011) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2011.05.005 · Cited by 44
Self-citationYang, M.-H., Tyan, Y., Huang, Y.-H., Wang, S., & Chen, S. (2016) · La radiologia medica · doi:10.1007/s11547-016-0662-1 · Cited by 44
Clinical Characteristics and Postoperative Outcomes of Primary Aldosteronism in the Elderly
Takeda, M., Yamamoto, K. I., Akasaka, H., Rakugi, H., Naruse, M., Takeda, Y., Kurihara, I., Itoh, H., Umakoshi, H., Tsuiki, M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00059 · Cited by 44
Ahn, S. H., Kim, J. H., Baek, S. H., Kim, H., Cho, Y. Y., Suh, S., Kim, B.-J., Hong, S., Koh, J.-M., Lee, S. H., et al. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.4.501 · Cited by 43
Westerdahl, C., Bergenfelz, A. O. J., Isaksson, A., Nerbrand, C., & Valdemarsson, S. V. (2011) · Europe PMC (PubMed Central) · doi:10.3109/02813432.2011.554015 · Cited by 43
Unilateral adrenal hyperplasia: A novel cause of surgically correctable primary hyperaldosteronism
Iacobone, M., Citton, M., Viel, G., Boetto, R., Bonadio, I., Tropea, S., Mantero, F., Rossi, G. P., Fassina, A., Nitti, D., et al. (2012) · Surgery · doi:10.1016/j.surg.2012.08.042 · Cited by 43
Self-citationKline, G. A., So, B., Dias, V. C., Harvey, A. M., & Pasieka, J. L. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12096 · Cited by 43
Bandulik, S., Tauber, P., Pentón, D., Schweda, F., Tegtmeier, I., Sterner, C. W., Lalli, E., Lesage, F., Hartmann, M. F., Barhanin, J., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1101 · Cited by 43
Potential effects of age on screening for primary aldosteronism
Luo, Q., Li, N.-F., Yao, X.-G., Zhang, D. L., Abulikemu, S.-F.-Y., Chang, G., Zhou, K.-M., Wang, G.-L., Wang, M. H., Ouyang, W.-J., et al. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.21 · Cited by 43
Progress in Primary Aldosteronism: Present Challenges and Perspectives
Gómez-Sánchez, C. E., Rossi, G. P., Fallo, F., & Mannelli, M. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1243619 · Cited by 43
Clinicopathological correlates of adrenal Cushing's syndrome
Duan, K., Hernandez, K., & Mete, Ö. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202612 · Cited by 43
Grübler, M. R., Gaksch, M., Kienreich, K., Verheyen, N., Schmid, J., Hartaigh, B. W. J. Ó., Richtig, G., Scharnagl, H., Meinitzer, A., Pieske, B. M., et al. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12825 · Cited by 43
Primary Aldosteronism and Obstructive Sleep Apnea: Is This A Bidirectional Relationship?
Prejbisz, A., Kołodziejczyk‐Kruk, S., Lenders, J. W. M., & Januszewicz, A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-122887 · Cited by 43
Xekouki, P., Hatch, M. M., Lin, L., de Alexandre, R. B., Azevedo, M. F., Sierra, M. D. L. L., Levy, I., Saloustros, E. S., Moraitis, A. G., Horvath, A., et al. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0022 · Cited by 42
Familial and Phenotypic Associations of the Aldosterone Renin Ratio
Alvarez‐Madrazo, S., Padmanabhan, S., Mayosi, B. M., Watkins, H. C., Avery, P. J., Wallace, A. M., Fraser, R., Davies, E., Keavney, B. D., & Connell, J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1406 · Cited by 42
Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone
Pia, A. R., Vignani, F., Attard, G., Tucci, M., Bironzo, P., Scagliotti, G. V., Arlt, W., Terzolo, M., & Berruti, A. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.003 · Cited by 42
Nuclear imaging in the diagnosis of primary aldosteronism
Powlson, A., Gurnell, M., & Brown, M. J. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000148 · Cited by 42
Rossi, E., Perazzoli, F., Negro, A., & Magnani, A. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001384 · Cited by 42
Hu, Y., Zhang, J., Liu, W., & Su, X. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz293 · Cited by 43
Cystic adrenal lesions: Clinical and surgical management. The experience of a referral centre
Cavallaro, G., Crocetti, D., Paliotta, A., Gori, A. D., Tarallo, M., Letizia, C., & Toma, G. D. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.11.023 · Cited by 42
Volpe, C., Hamberger, B., Höög, A., Mukai, K., Calissendorff, J., Wahrenberg, H., Zedenius, J., & Thorén, M. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12645 · Cited by 41
Lonati, C., Bassani, N., Gritti, A., Biganzoli, E. M., & Morganti, A. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000076 · Cited by 41
New insights into aldosterone-producing adenomas and hereditary aldosteronism
Scholl, U. I., & Lifton, R. P. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32835cecf8 · Cited by 41
Ishidoya, S., Kaiho, Y., Ito, A., Morimoto, R., Satoh, F., Ito, S., Ishibashi, T., Nakamura, Y., Sasano, H., & Arai, Y. (2011) · Urology · doi:10.1016/j.urology.2010.12.042 · Cited by 41
Indra, T., Holaj, R., Štrauch, B., Rosa, J., Petrák, O., Krátká, Z., & Widimsky, J., Jr. (2014) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320314549220 · Cited by 42
Inherited forms of mineralocorticoid hypertension
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.010 · Cited by 41
Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism
van der Linden, P., Steichen, O., Zinzindohoué, F., & Plouin, P. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328350225d · Cited by 42
Pharmacological treatment of aldosterone excess
Deinum, J., Riksen, N. P., & Lenders, J. W. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.006 · Cited by 41
Kline, G. A., Pasieka, J. L., Harvey, A. M., So, B., & Dias, V. C. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12342 · Cited by 41
Funder, J. W. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.03.005 · Cited by 40
Self-citationDouglas, G., Axelrad, M. E., Brandt, M. L., Crabtree, E. A., Dietrich, J. E., French, S. L., Gunn, S., Karaviti, L. P., López, M. E., Macias, C. G., et al. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/919707 · Cited by 46
Trésallet, C., Salepçioglu, H., Godiris-Petit, G., Hoang, C., Girerd, X. J., & Ménégaux, F. (2010) · Surgery · doi:10.1016/j.surg.2009.11.020 · Cited by 40
Optimum position of left adrenal vein sampling for subtype diagnosis in primary aldosteronism
Umakoshi, H., Wada, N., Ichijo, T., Kamemura, K., Matsuda, Y., Fuji, Y., Kai, T., Fukuoka, T., Sakamoto, R., Ogo, A., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12847 · Cited by 41
Aldosterone, Renin, Cardiovascular Events, and All-Cause Mortality Among African Americans
Joseph, J. J., Echouffo-Tcheugui, J. B., Kalyani, R. R., Yeh, H., Bertoni, A. G., Effoe, V. S., Casanova, R., Sims, M., Wu, W.-C., Wand, G. S., et al. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.05.012 · Cited by 40
Kocjan, T., Janež, A., Stankovič, M., Vidmar, G., & Jensterle, M. (2016) · Endocrine Practice · doi:10.4158/ep15982.or · Cited by 40
Endocrine hypertension: An overview on the current etiopathogenesis and management options
Thomas, R. M. (2015) · World Journal of Hypertension · doi:10.5494/wjh.v5.i2.14 · Cited by 40
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling
Rossi, G. P., Battistel, M., Seccia, T. M., Rossi, F. B., & Rossitto, G. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf007 · Cited by 39
Sarlon-Bartoli, G., Michel, N., Taïeb, D., Mancini, J., Gonthier, C., Silhol, F., Muller, C., Bartoli, J., Sebag, F. A., Henry, J., et al. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834666af · Cited by 39
Chrissobolis, S., Drummond, G. R., Faraci, F. M., & Sobey, C. G. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000259 · Cited by 39
Adrenal Incidentalomas: Clinical Controversies and Modified Recommendations
Garrett, R. W., Nepute, J., Hayek, M. E., & Albert, S. G. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.15.15475 · Cited by 41
Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms
Heinrich, D. A., Adolf, C., Rump, L. C., Quack, I., Quinkler, M. O., Hahner, S., Januszewicz, A., Seufert, J., Willenberg, H. S., Nirschl, N., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0978 · Cited by 39
Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study
Köhler, A., Sarkis, A., Heinrich, D. A., Müller, L., Handgriff, L., Deniz, S., Schneider, H., Kunzel, H. E., Ladurner, R., Reincke, M., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0018 · Cited by 39
Role of the endothelium and blood stasis in the development of varicose veins.
Michiels, C., Bouaziz, N., & Remacle, J. (2002) · PubMed · Cited by 38
Aldosteronism and Resistant Hypertension
Acelajado, M. C., & Calhoun, D. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/837817 · Cited by 39
Camenzind, A. G., van der Gugten, J. G., Popp, R., Holmes, D. T., & Borchers, C. H. (2013) · Clinical Proteomics · doi:10.1186/1559-0275-10-20 · Cited by 38
Regulation of aldosterone secretion by Cav1.3
Xie, C. B., Shaikh, L. H., Garg, S., Tanriver, G., Teo, A. E. D., Zhou, J., Maniero, C., Zhao, W., Kang, S., Silverman, R. B., et al. (2016) · Scientific Reports · doi:10.1038/srep24697 · Cited by 42
Christa, M., Weng, A. M., Geier, B., Wörmann, C., Scheffler, A., Lehmann, L., Oberberger, J., Kraus, B. J., Hahner, S., Störk, S., et al. (2018) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jey134 · Cited by 37
Wu, V., Kuo, C., Chang, H., Tsai, C., Lin, C., Lin, L., Lin, Y., Wang, S., Huang, K., Fang, C., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.027 · Cited by 38
Fischer, E., Hannemann, A., Rettig, R., Lieb, W., Nauck, M., Pallauf, A., Bildingmaier, M., Beuschlein, F., Wallaschofski, H., & Reincke, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3214 · Cited by 37
Diagnosis and treatment of primary aldosteronism
Rossi, G. P. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9162-8 · Cited by 37
Diagnosis and Treatment of Primary Aldosteronism
Rossi, G. P. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.005 · Cited by 37
Sarzani, R., Guerra, F., Mancinelli, L., Buglioni, A., Franchi, E., & Dessı̀-Fulgheri, P. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.47 · Cited by 37
Seccia, T. M., Mantero, F., Letizia, C., Kuppusamy, M., Caroccia, B., Barisa, M., Cicala, M. V., D, D. M. M., & Rossi, G. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2342 · Cited by 37
Self-citationKobayashi, H. H., Haketa, A., Ueno, T., Ikeda, Y., Hatanaka, Y., Tanaka, S., Otsuka, H., Abe, M., Fukuda, N., & Soma, M. (2016) · Clinical Endocrinology · doi:10.1111/cen.13278 · Cited by 37
Hacini, I., Sousa, K. D., Boulkroun, S., Méatchi, T., Amar, L., Zennaro, M., & Fernandes-Rosa, F. L. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0338 · Cited by 37
Juutilainen, A., Savolainen, K., Romppanen, J., Turpeinen, U., Hämäläinen, E. K., Kemppainen, J., Moilanen, L., & Pulkki, K. J. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.015 · Cited by 37
Surgical management of adrenal tumors
Germain, A., Klein, M., & Brunaud, L. (2011) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2011.06.003 · Cited by 37
Endocrine incidentalomas—challenges imposed by incidentally discovered lesions
Vassiliadi, D. A., & Tsagarakis, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.92 · Cited by 37
Genetics of Hypertensive Syndrome
Martínez‐Aguayo, A., & Fardella, C. (2009) · Hormone Research in Paediatrics · doi:10.1159/000208798 · Cited by 37
Self-citationCapítulo 3 - Avaliação Clínica e Complementar
Malachias, M. V. B., Souza, W., Plavnik, F. L., Rodrigues, C., Brandão, A., Neves, M. F., Bortolotto, L. A., Franco, R., Figueiredo, C., Jardim, P., et al. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160153 · Cited by 38
Screening for Adrenal-Endocrine Hypertension: Overview of Accuracy and Cost-effectiveness
Schwartz, G. L. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.02.001 · Cited by 36
Turchi, F., Ronconi, V., di Tizio, V., Ceccoli, L., Boscaro, M., & Giacchetti, G. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.09.009 · Cited by 36
Metadata
- Authors
- Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M.
- Affiliations
- Prince Henry’s Institute of Medical Research (J.W.F.), Clayton VIC 3168, Australia
- University of Virginia Health System (US)
- Pontificia Universidad Católica de Chile (CL)
- G.V. (Sonny) Montgomery VA Medical Center (C.E.G.-S.), Jackson, Mississippi 39216
- University of Padua (IT)
- The University of Queensland (AU)
- Mayo Clinic (US)
- Mayo Clinic (W.F.Y., V.M.M.), Rochester, Minnesota 55902
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-09-01
- Volume
- 93
- Issue
- 9
- Pages
- 3266-3281
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2156903075
- Cited by
- 1,554
- References
- 145
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 34 · 2023: 42 · 2022: 42 · 2021: 51 · 2020: 50 · 2019: 56 · 2018: 70 · 2017: 84 · 2016: 158 · 2015: 182 · 2014: 135 · 2013: 127 · 2012: 169
- FWCI
- 72.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- primary aldosteronism, case finding, aldosterone-renin ratio, confirmatory testing, adrenal computed tomography, unilateral primary aldosteronism, laparoscopic adrenalectomy, bilateral adrenal hyperplasia, mineralocorticoid receptor antagonists, hypertension, hypokalemia
- MeSH terms
- Eplerenone, Mineralocorticoid Receptor Antagonists, Algorithms, Catheterization, Combined Modality Therapy, Cosyntropin, Diagnostic Techniques, Endocrine, Humans, Hyperaldosteronism, Spironolactone, Reproducibility of Results, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
